In the evolving landscape of the China epilepsy market, the emphasis on innovative treatments is becoming more pronounced. With a market size expected to expand to USD 570 million by 2035, the anticipated CAGR of 5.39% highlights a growing public health concern. This growth is not merely a reflection of the increasing number of epilepsy cases but is also driven by the advancements in technology...

Oxcarb 300, which is also known as Oxcarbazepine 300 mg, is a widely prescribed anticonvulsant medication used primarily to manage seizure disorders and support long-term brain health. By stabilizing abnormal electrical activity in the brain, Oxcarb 300 helps reduce seizure frequency and protects neurological function. This medication is mainly targeted in the US, where it plays a significant...